Related Experiment Video
Updated: Aug 15, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Significance of serum calcium and phosphorus control for the cardiac function in patients with long term
Atsushi Onoue1, Yasuaki Higashino, Takashi Ohno
1Chouju Clinic Division of Ultrasound.
Insights
Serum calcium and phosphorus levels do not directly cause cardiomegaly in hemodialysis patients. However, controlling serum phosphorus is crucial for inhibiting cardiomegaly progression, as it correlates positively with left ventricular mass index (LVMI).
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Context:
- Hemodialysis patients frequently develop cardiac valve calcification.
- Calcification correlates with increased left ventricular mass index (LVMI), a marker of cardiomegaly.
- Existing research on the impact of serum calcium and phosphorus on cardiomegaly is limited.
Purpose:
- To investigate the relationship between serum calcium and phosphorus levels and cardiomegaly in hemodialysis patients.
- To determine if serum calcium and phosphorus influence the progression of cardiac valve calcification and LVMI.
Summary:
- Cardiac valve calcification is prevalent in hemodialysis patients, affecting 44% of mitral valves and 75% of aortic valves.
- While serum calcium and phosphorus did not directly cause cardiomegaly, a significant negative correlation was found between serum calcium and LVMI (P=0.0008).
- A significant positive correlation was observed between serum phosphorus and LVMI (P=0.0105), suggesting phosphorus control is key.
Impact:
- Findings suggest that managing serum phosphorus levels is a critical factor in preventing or inhibiting cardiomegaly in hemodialysis patients.
- This research highlights the importance of monitoring and controlling mineral metabolism in hemodialysis patients to mitigate cardiovascular complications.
- The study provides evidence-based recommendations for clinical practice regarding the management of hyperphosphatemia to reduce cardiac risks.
Abstract:
We evaluated how serum calcium and phosphorus will effect a cardiomegaly of hemodialysis patients. The cardiac valve of hemodialysis patients have a high incidence of calcification. Forty four percent of mitral valve and seventy five percent of aortic valve occurred the calcification, and the progress of calcification involve with increasing LVMI. The consequence of this results was that we consider prevent calcification is important to inhibiting factor of cardiomegaly, but serum calcium and phosphorus wasn't effect a cardiomegaly. On the other hand, we detected a significant negative correlation between serum calcium and LVMI (P = 0.0008) and a significant positive correlation between serum phosphorus and LVMI (P = 0.0105) . Consequently we thought that to control the serum phosphorus is important factor to inhibit the cardiomegaly.
Related Concept Videos
Skeleton and Calcium Homeostasis
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Chronic Kidney Disease III: Interprofessional Care
Peritoneal Dialysis III: Nursing Management
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations